Harpoon Therapeutics, Inc. (HARP)
NASDAQ: HARP · IEX Real-Time Price · USD
0.716
+0.031 (4.54%)
Jun 2, 2023, 11:53 AM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 31.92 | 23.65 | 17.44 | 5.78 | 4.75 | 0.71 | 0 |
| Revenue Growth (YoY) | 34.92% | 35.60% | 201.96% | 21.62% | 570.90% | - | - |
| Gross Profit | 31.92 | 23.65 | 17.44 | 5.78 | 4.75 | 0.71 | 0 |
| Selling, General & Admin | 18.85 | 18.33 | 16.21 | 22.39 | 6.11 | 3.61 | 3.37 |
| Research & Development | 81.39 | 72.12 | 52.57 | 41.59 | 26.37 | 13.62 | 7.78 |
| Other Operating Expenses | 0.18 | 50.16 | 0.03 | 0.04 | 0.04 | 0.1 | 0 |
| Operating Expenses | 100.42 | 140.62 | 68.8 | 64.03 | 32.51 | 17.33 | 11.15 |
| Operating Income | -68.51 | -116.96 | -51.36 | -58.25 | -27.76 | -16.62 | -11.15 |
| Interest Expense / Income | 0 | 0 | 0 | 0 | 0 | 0.29 | 0.26 |
| Other Expense / Income | -0.78 | -0.24 | -1.45 | -2.68 | -0.4 | -0.08 | -0.01 |
| Pretax Income | -67.73 | -116.72 | -49.91 | -55.57 | -27.37 | -16.83 | -11.41 |
| Net Income | -67.73 | -116.72 | -49.91 | -55.57 | -27.37 | -16.83 | -11.41 |
| Shares Outstanding (Basic) | 33 | 32 | 25 | 22 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 33 | 32 | 25 | 22 | 1 | 1 | 1 |
| Shares Change | 2.77% | 28.92% | 15.12% | 1938.33% | 19.22% | 69.51% | - |
| EPS (Basic) | -2.04 | -3.62 | -1.99 | -2.56 | -25.65 | -18.81 | -21.61 |
| EPS (Diluted) | -2.04 | -3.62 | -1.99 | -2.56 | -25.65 | -18.81 | -21.61 |
| Free Cash Flow Per Share | -2.70 | -3.79 | -0.37 | -0.29 | -26.05 | -0.63 | -21.49 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - |
| Operating Margin | -214.65% | -494.47% | -294.41% | -1008.27% | -584.44% | -2347.88% | - |
| Profit Margin | -212.22% | -493.45% | -286.10% | -961.95% | -576.13% | -2377.12% | - |
| Free Cash Flow Margin | -280.52% | -516.84% | -53.31% | -110.91% | -585.03% | -79.24% | - |
| EBITDA | -64.63 | -114.08 | -47.39 | -53.47 | -26.72 | -16.18 | -10.95 |
| EBITDA Margin | -202.52% | -482.27% | -271.69% | -925.57% | -562.57% | -2285.17% | - |
| Depreciation & Amortization | 3.1 | 2.65 | 2.51 | 2.1 | 0.64 | 0.37 | 0.2 |
| EBIT | -67.73 | -116.72 | -49.91 | -55.57 | -27.37 | -16.55 | -11.15 |
| EBIT Margin | -212.22% | -493.45% | -286.10% | -961.95% | -576.13% | -2336.86% | - |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).